Morgan Stanley Iridex Corp Transaction History

Morgan Stanley

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 17, 2024	BUY	$2.35 - $3.1 $1,621 - $2,139	690 New	690 $2,000
Q4 2023 Aug 16, 2024	BUY	$1.9 - $3.28 $1,311 - $2,263	690 New	690 $1,000
Q4 2023 Feb 13, 2024	SELL	$1.9 - $3.28 $117 - $203	-62 Reduced 8.24%	690 $1,000
Q2 2023 Aug 14, 2023	SELL	$1.76 - $2.43 $34,304 - $47,363	-19,491 Reduced 96.29%	752 $1,000
Q1 2023 May 15, 2023	BUY	$2.0 - $2.46 $38,560 - $47,428	19,280 Added 2002.08%	20,243 $41,000
Q4 2022 Feb 14, 2023	SELL	$2.0 - $2.63 $1,120 - $1,472	-560 Reduced 36.77%	963 $1,000
Q2 2022 Oct 27, 2022	SELL	$2.48 - $4.66 $2,452 - $4,608	-989 Reduced 39.37%	1,523 $4,000
Q2 2022 Aug 15, 2022	SELL	$2.48 - $4.66 $2,452 - $4,608	-989 Reduced 39.37%	1,523 $4,000
Q1 2022 Oct 27, 2022	BUY	$3.99 - $6.42 $3,946 - $6,349	989 Added 64.94%	2,512 $12,000
Q1 2022 May 13, 2022	BUY	$3.99 - $6.42 $1,364 - $2,195	342 Added 15.76%	2,512 $12,000
Q4 2021 Feb 14, 2022	SELL	$5.62 - $9.37 $32,893 - $54,842	-5,853 Reduced 72.95%	2,170 $13,000
Q3 2021 Nov 15, 2021	BUY	$6.29 - $7.98 $50,464 - $64,023	8,023 New	8,023 $61,000

3.25M

500

61.3K

Ticker IRIX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 15,985,600
Market Cap $22.2M
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.